What a GI-MAP Reveals That a Standard Stool Test Misses

Jun 9

If you have ever been told your stool test came back normal, you may not have had the full picture.

Standard stool cultures check for a narrow list of pathogens. They are designed to rule out active infection. What they do not assess is the broader functional state of your gut, including the balance of your microbial community, the integrity of your intestinal lining, the status of your mucosal immune defenses, or the presence of low-grade inflammation.

The GI-MAP, developed by Diagnostic Solutions Laboratory, uses quantitative polymerase chain reaction (qPCR) technology to detect and measure a much wider range of microbial and functional markers. For women with ADHD, PMDD, hormonal symptoms, or fatigue that has not responded to standard approaches, the gut picture is often part of the clinical story. This post explains what the GI-MAP looks at, what the key markers mean, and why a standard stool test would have missed them.

Standard Stool Tests vs. Functional Testing: What Is the Difference?

A standard stool culture identifies whether a specific pathogen is present above a detectable threshold. It is the right tool for ruling out acute infection from organisms like Salmonella, Campylobacter, or E. coli in the context of acute illness.

What it does not look at:

The balance of commensal bacteria in the gut and whether beneficial species are adequate
Levels of intestinal inflammation markers like calprotectin
Mucosal immune function via secretory IgA
Markers of intestinal permeability
H. pylori status with virulence factor assessment
Opportunistic pathogens that can cause chronic low-grade dysfunction without triggering acute illness

The GI-MAP was designed specifically to assess functional and chronic patterns, not just acute infections. This distinction matters significantly when evaluating patients whose symptoms are chronic, diffuse, and not explained by standard testing.

The Gut-Brain Connection Is Not a Theory

Understanding why the gut matters for ADHD, PMDD, and hormonal symptoms requires understanding the microbiome-gut-brain axis, the bidirectional communication system between the gut microbiota and the central nervous system.

This axis operates through three interconnected pathways: the nervous system, the neuroendocrine system, and the immune system (Checa-Ros et al., 2021).

Through these pathways, the gut microbiome influences the production of neurotransmitters including serotonin, dopamine, GABA, and norepinephrine. Alterations in gut microbial composition have been associated with disruptions in catecholaminergic and serotonergic neurotransmission, both of which are central to the pathophysiology of ADHD (Checa-Ros et al., 2021).

Enterochromaffin cells in the gut epithelium are responsible for producing more than 90% of the peripheral serotonin in the body (Chen et al., 2021). Serotonin produced in the gut plays a critical role in intestinal motility, immune regulation, and neuroendocrine signaling. Disrupted gut serotonin production has been associated with a range of neurological and metabolic conditions (Chen et al., 2021).

The gut microbiome also regulates the hypothalamic-pituitary-adrenal (HPA) axis, the body's central stress response system. Dysbiosis has been shown to exaggerate HPA axis reactivity, which in turn affects cortisol patterns, immune regulation, and downstream hormonal signaling (Checa-Ros et al., 2021).

For women with PMDD, there is an additional layer. The gut microbiome contains a subset of microbial genes called the estrobolome, which regulate estrogen metabolism through the production of the enzyme beta-glucuronidase. This enzyme deconjugates estrogen metabolites in the gut, enabling their reabsorption into systemic circulation. Dysbiosis that alters the estrobolome can disrupt estrogen reabsorption, contributing to either estrogen deficiency or estrogen excess depending on the direction of the disruption. Both have implications for hormonal symptom patterns including PMDD and luteal phase instability (Escorcia Mora et al., 2025).

Key GI-MAP Markers and What They Mean

Below is a lay-audience translation of the markers that appear most clinically relevant for the populations seen in functional medicine practice.

H. pylori

Helicobacter pylori is a bacterium that colonizes the gastric lining and is one of the most prevalent bacterial infections globally. What makes H. pylori particularly relevant from a functional standpoint is its effect on nutrient absorption. H. pylori infection is associated with impaired absorption of iron, vitamin B12, and other micronutrients through its effect on gastric acid production and the gastric mucosa (Leung et al., 2024). In patients where ferritin or B12 remains low despite supplementation, H. pylori is one of the first things worth assessing.

The GI-MAP does not just detect H. pylori presence. It also identifies virulence factor genes including VacA and CagA, which help characterize how aggressive the strain is and what the clinical risk profile looks like.

Dietary management of H. pylori can also support treatment protocols. Foods with documented activity against H. pylori include cruciferous vegetables, berries, garlic, cranberry, and certain culinary herbs including curcumin and ginger. High-salt diets, smoked or preserved foods, and foods high in nitrites have been associated with increased H. pylori virulence and colonization (Diagnostic Solutions Laboratory, 2024).

Secretory IgA (SIgA)

Secretory IgA is the most abundant antibody in the intestinal lumen and serves as the first line of mucosal immune defense. It protects the intestinal epithelium from enteric pathogens and toxins through a process called immune exclusion, blocking pathogen attachment, entrapping organisms in mucus, and facilitating their removal through peristalsis (Mantis et al., 2011).

SIgA also plays a role in regulating the composition of the gut microbiome and in maintaining mucosal homeostasis by down-regulating pro-inflammatory responses to certain antigens (Mantis et al., 2011).

Low secretory IgA on the GI-MAP indicates a compromised mucosal immune barrier. This is commonly seen in individuals with chronic stress, HPA axis dysregulation, or nutritional deficiencies. Elevated SIgA can indicate active mucosal immune activation in response to ongoing antigenic challenge.

Calprotectin

Fecal calprotectin is a well-established marker of intestinal inflammation. It is released from neutrophils and other immune cells during inflammatory activity in the gut lining. Elevated calprotectin indicates active intestinal inflammation and is used clinically to differentiate inflammatory bowel conditions from functional disorders.

In the context of ADHD and PMDD, elevated gut inflammation is clinically relevant because systemic inflammatory signaling affects neurotransmitter metabolism, HPA axis function, and immune-hormonal crosstalk. The microbiome-gut-brain axis research is clear that gut dysbiosis contributes to neuroinflammatory states that can amplify ADHD-related symptoms including oxidative stress and mitochondrial dysfunction (Checa-Ros et al., 2021).

Zonulin (Intestinal Permeability)

Zonulin is a protein that regulates the tight junctions between intestinal epithelial cells. When tight junction integrity is compromised, the intestinal barrier becomes more permeable, allowing bacterial products, dietary antigens, and other macromolecules to enter systemic circulation. This is commonly referred to as increased intestinal permeability or leaky gut.

Gut microbiome alterations downregulate the expression of tight junction proteins, and this change in barrier integrity has been associated with both systemic and neuroinflammatory processes (Checa-Ros et al., 2021). Increased intestinal permeability exposes both the gut and the blood-brain barrier to biomacromolecules that can trigger immune activation and neuroinflammation.

Zonulin elevation on the GI-MAP provides direct evidence of impaired intestinal barrier function, which can be a driver of chronic systemic inflammation even in the absence of frank gastrointestinal symptoms.

Commensal Bacteria and Dysbiosis Patterns

The GI-MAP quantifies the levels of key commensal bacteria, including beneficial species like Lactobacillus, Bifidobacterium, Akkermansia muciniphila, and Faecalibacterium prausnitzii, as well as opportunistic bacteria that can overgrow in the context of dysbiosis.

Multiple studies have found differences in gut microbial composition in children and adults with ADHD compared to controls. Consistent findings across several studies include reduced levels of Faecalibacterium, a genus with well-established anti-inflammatory properties, in individuals with ADHD (Checa-Ros et al., 2021). Other patterns include alterations in microbial genes involved in dopamine and serotonin metabolic pathways, suggesting that gut microbial composition may influence neurotransmitter availability (Checa-Ros et al., 2021).

The current evidence base is heterogeneous and does not yet support identifying a single microbial profile specific to ADHD. However, what is clear is that gut microbial composition influences the pathways that are relevant to ADHD symptoms, including dopaminergic neurotransmission, serotonin production, HPA axis regulation, and neuroinflammation.

What These Patterns Look Like in Women with ADHD and PMDD

The intersection of gut dysfunction with ADHD and PMDD is not coincidental. The mechanisms are directly connected.

Gut dysbiosis drives systemic low-grade inflammation. That inflammation activates the HPA axis, disrupts cortisol rhythms, and affects immune-hormonal signaling in ways that amplify both ADHD symptom severity and luteal phase reactivity.

Reduced beneficial bacteria and compromised mucosal immunity mean that estrogen metabolism through the estrobolome becomes dysregulated. When gut dysbiosis alters beta-glucuronidase activity, estrogen reabsorption from the gut is disrupted. Depending on the direction of the shift, this can contribute to either estrogen deficiency or excess recirculation, both of which create hormonal instability during the luteal phase (Escorcia Mora et al., 2025).

Low secretory IgA, a marker of mucosal immune compromise, is commonly associated with chronic HPA axis dysregulation, which is itself a feature of the ADHD nervous system. This creates a cycle where stress dysregulation compromises gut immune function, gut immune dysfunction amplifies systemic inflammation, and systemic inflammation worsens neurotransmitter instability and hormonal sensitivity.

Gut permeability, when elevated, allows bacterial products including lipopolysaccharide (LPS) to enter systemic circulation. LPS is a potent driver of neuroinflammation and has been associated with worsening mood, cognitive symptoms, and fatigue in ways that overlap significantly with PMDD and ADHD presentations.

A standard stool test would not identify any of these patterns.

What a Standard Stool Test Would Have Missed

To make this concrete: if a woman with ADHD, PMDD, and persistent fatigue had a standard stool culture, it would tell her whether she had an acute infection. If it came back negative, she would be told her gut is fine.

A GI-MAP on the same patient might reveal:

H. pylori that has been quietly impairing iron and B12 absorption for years
Low secretory IgA indicating a compromised mucosal immune barrier
Elevated calprotectin showing active gut inflammation not producing obvious GI symptoms
Elevated zonulin showing intestinal permeability driving systemic inflammatory load
Reduced Faecalibacterium and disrupted microbial balance affecting neurotransmitter metabolism and HPA axis regulation
Dysbiosis patterns that are altering estrogen metabolism through the estrobolome

None of these would appear on a standard stool culture. All of them are clinically relevant for her symptom picture.

Clinical Takeaways

The gut is not a separate system from the brain, the hormones, or the immune system. It is a central hub through which all of these systems communicate.

For women with ADHD, PMDD, fatigue, or hormonal symptoms that have not responded to standard approaches, a GI-MAP can reveal the functional patterns that standard testing is not designed to find. It does not replace clinical judgment or other testing, but it adds a layer of information that is often missing from the picture.

The GI-MAP is part of the functional lab panel used in the 3-Month Functional Lab Package at Botanical Health Clinic, alongside organic acids testing and comprehensive blood chemistry. The goal is not to order a test for its own sake, but to understand what patterns are actually driving your symptoms.

Want to Understand What Your Gut Is Actually Doing?

The GI-MAP is included in the 3-Month Functional Lab Package at Botanical Health Clinic, alongside an organic acids test and comprehensive blood chemistry. Together these tests build a complete functional picture of what is driving your symptoms.

If you are curious whether this kind of deeper investigation is the right next step for you, the best place to start is a free discovery call. We will talk through your history, your symptoms, and whether the 3-month package makes sense for where you are right now.

Book a free discovery call here

References

Checa-Ros, A., Jeréz-Calero, A., Molina-Carballo, A., Campoy, C., & Muñoz-Hoyos, A. (2021). Current evidence on the role of the gut microbiome in ADHD pathophysiology and therapeutic implications. Nutrients, 13(1), 249. https://doi.org/10.3390/nu13010249

Chen, Z., Luo, J., Li, J., Kim, G., Stewart, A., Urban, J. F., Huang, Y., Chen, S., Wu, L.-G., Chesler, A., Trinchieri, G., Li, W., & Wu, C. (2021). Interleukin-33 promotes serotonin release from enterochromaffin cells for intestinal homeostasis. Immunity, 54(1), 151–163.e6. https://doi.org/10.1016/j.immuni.2020.10.014

Diagnostic Solutions Laboratory. (2024). Diet for managing Helicobacter pylori levels: Quick reference guide. Diagnostic Solutions Laboratory.

Escorcia Mora, P., Valbuena, D., & Diez-Juan, A. (2025). The role of the gut microbiota in female reproductive and gynecological health: Insights into endometrial signaling pathways. Life, 15(5), 762. https://doi.org/10.3390/life15050762

Leung, A. K. C., Lam, J. M., Wong, A. H. C., Hon, K. L., & Li, X. (2024). Iron deficiency anemia: An updated review. Current Pediatric Reviews, 20(3), 339–356. https://doi.org/10.2174/1573396320666230727102042

Mantis, N. J., Rol, N., & Corthésy, B. (2011). Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunology, 4(6), 603–611. https://doi.org/10.1038/mi.2011.41